Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Erythema multiforme
ADR ID BADD_A01540
ADR Hierarchy
10      Immune system disorders
10.01      Allergic conditions
10.01.03      Allergic conditions NEC
10.01.03.015      Erythema multiforme
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.01      Bullous conditions
23.03.01.003      Erythema multiforme
Description A disorder characterized by target lesions (a pink-red ring around a pale center). [CTCAE] A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic "bull's-eye" lesions usually occurring on the dorsal aspect of the hands and forearms. [MeSH]
MedDRA Code 10015218
MeSH ID D004892
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Bullous erythema multiforme | EM | Erythema exsudativum multiforme | Erythema exudativum | Erythema exudativum multiforme | Erythema multiform-like eruption | Erythema multiforme | Erythema multiforme exudativum | Erythema multiforme major | Erythema multiforme minor | Erythema multiforme severe | Erythema multiforme type skin reaction | Erythema multiforme type vasculitis | Erythema polymorphe | Erythaema polymorphe | EMPACT syndrome | Erythema multiforme associated with phenytoin and cranial radiation therapy syndrome | Oral erythema multiforme | Erythema Multiforme
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01546Nefazodone--
BADD_D01548Nefopam--
BADD_D01550Nelfinavir mesylate--
BADD_D01557Nevirapine--
BADD_D01558Nexium--
BADD_D01566Nifedipine--
BADD_D01567Nilotinib0.000280%
BADD_D01576Nitrofurantoin--
BADD_D01577Nitrofurantoin (macrocrystals)--
BADD_D01578Nitrofurantoin (monohydrate/macrocrystals)--
BADD_D01581Nivolumab--
BADD_D01585Norethindrone--
BADD_D01586Norethindrone acetate--
BADD_D01587Norfloxacin--
BADD_D01591Nystatin--
BADD_D01596Ofatumumab--
BADD_D01598Ofloxacin--
BADD_D01601Olaparib0.000224%
BADD_D01614Omeprazole--
BADD_D01615Omeprazole magnesium--
BADD_D01616Onabotulinumtoxina--
BADD_D01617Ondansetron--
BADD_D01621Optimark--
BADD_D01623Oritavancin--
BADD_D01624Orlistat0.005655%
BADD_D01627Oseltamivir--
BADD_D01628Oseltamivir phosphate--
BADD_D01629Osimertinib0.001455%
BADD_D01633Oxaliplatin--
BADD_D01635Oxaprozin--
The 14th Page    First    Pre   14 15 16 17 18    Next   Last    Total 20 Pages